Prostate Cancer UK: PET-CT Access.

Policy Team made this Freedom of Information request to Northern Lincolnshire and Goole Hospitals NHS Foundation Trust as part of a batch sent to 18 authorities

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

Northern Lincolnshire and Goole Hospitals NHS Foundation Trust did not have the information requested.

Dear Northern Lincolnshire and Goole Hospitals NHS Foundation Trust,

This Freedom of Information Act (FOI) Request of all Trusts, Health Boards and Health and Social Care Trusts aims to give us an overview of access to PET-CT for prostate cancer across the UK. We will use this information to guide activity aimed at service improvements and reduced variation in access. We hope to understand and share best practice to allow all men with biochemical recurrence to gain access to the most accurate diagnostic technology. Please be reassured that, if published, the results will remain anonymous and respondents unidentifiable. We will not criticise any individual respondent.
Your responses are greatly appreciated. Please pass these questions to your radiology and/or urology departments for them to complete. If this is not possible, please provide as much information as you can.
In any multiple-choice questions, we ask that you please indicate your answer by marking with an “X” next to any answers that apply or by deleting all answers that do not apply. Please avoid answering by italics, underlining or bold, as these do not show up when we process your response.

Many thanks,
Prostate Cancer UK

1. Does your trust/ HB have access to PET-CT for the investigation of suspected biochemical recurrence in prostate cancer patients?
a. Yes
b. Not on site, but we refer patients elsewhere (please state the trust/HB patients are referred to, if possible:)
c. No

2. If you answered “No” to question 1. Would you use PET-CT for the investigation of suspected biochemical recurrence in prostate cancer patients if it were available?
a. Yes
b. No
c. N/A - We already have access to PET-CT.

3. In 2020-21, how many patients do you estimate were investigated for suspected biochemical recurrence of prostate cancer at your trust/ HB?

4. What percentage of patients with suspected biochemical recurrence do you estimate are referred for PET-CT at your trust/ HB?

5. Of patients with suspected biochemical recurrence referred for PET-CT, what % of scans do you estimate use a PSMA tracer (either Ga-PSMA or F-PSMA)?

6. Are there any exclusion criteria for referral for PET-CT for suspected biochemical recurrence of prostate cancer? If so, what are they? E.g. Upper and lower PSA limits, age, life expectancy, ECOG score.

7. What do you estimate is the average waiting time for the PET-CT scans for investigation of suspected biochemical recurrence of prostate cancer?

8. What do you estimate is the average time it takes to report PET-CT scans for investigation of suspected biochemical recurrence of prostate cancer?

For any queries, please contact Tayla Maloney:
Telephone- [phone number]
Email- [email address]

Many thanks,
Tayla
Prostate Cancer UK

foi (NORTHERN LINCOLNSHIRE AND GOOLE NHS FOUNDATION TRUST), Northern Lincolnshire and Goole Hospitals NHS Foundation Trust

1 Attachment

 

 

Dear Tayla

 

Thank you for your Freedom of Information request below.

 

We will attempt to respond to you within 20 working days.

 

Please note: Your request for information may be delayed due to urgent
operational responses to dealing with Public Health priorities. We
apologise for any inconvenience this may cause, we do remain committed to
responding to your request and will respond as soon as we are able. Should
our response to your request breach the statutory timeframe and you remain
unhappy with our response you have the right to complain to the
Information Commissioners Office and you can contact them at

 

The Information Commissioner’s Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

 

Tel: 0303 123 1113

Website: [1]www.ico.org.uk

 

 

There is no charge for making an appeal.

 

Please find the link to the ICO’s COVID-19 response

 

[2]https://ico.org.uk/about-the-ico/news-an...

 

Kind regards

 

Freedom of Information Officer

Northern Lincolnshire and Goole NHS Foundation Trust

03033 306078/303318

[3][Northern Lincolnshire and Goole Hospitals NHS Foundation Trust request email]

 

 [4]cid:image001.jpg@01D4E3B2.381103B0

show quoted sections

foi (NORTHERN LINCOLNSHIRE AND GOOLE NHS FOUNDATION TRUST), Northern Lincolnshire and Goole Hospitals NHS Foundation Trust

 

Dear Tayla

 

Thank you for your Freedom of Information request below.

 

Please see our response below in red in your original email.

 

With reference to patient numbers or percentages, while we do record
patients (on the Somerset system) who have subsequent treatments, we don’t
record if they are diagnosed with biomedical recurrence.  Nor do we record
patients with an increase in PSA since the original diagnosis.  Therefore,
it would be impossible to identify this cohort of patients.

 

Kind regards

 

Adrian Beddow

Associate Director of Communications

Northern Lincolnshire and Goole NHS Foundation Trust

03033 303035

[1][email address]

 

 

show quoted sections